Skip to main content
NCBI home page
Gut logoLink to Gut
. 2001 Jan;48(1):97–102. doi: 10.1136/gut.48.1.97

Management and outcome of pregnancy in autoimmune hepatitis

M Heneghan 1, S Norris 1, J O'Grady 1, P Harrison 1, I McFarlane 1
PMCID: PMC1728166  PMID: 11115829

Abstract

BACKGROUND—There is a paucity of data in the literature on the risks associated with, and optimal management of, pregnancy in patients with autoimmune hepatitis (AIH).
AIMS—To assess maternal and fetal outcomes in relation to clinical management of pregnancy in a large cohort of patients with well defined AIH.
METHODS—A review of all known pregnancies in 162 females with definite AIH attending our clinics between 1983 and 1998, with respect to treatment, natural history, and outcome.
RESULTS—Thirty one live births (one twin) resulted from 35 pregnancies in 18 women (seven with cirrhosis). Median age at conception was 28 years (range 18-36). Two patients presented with AIH de novo during pregnancy. At conception, in 15 pregnancies patients had been receiving azathioprine alone or (in nine) with prednisolone, in seven prednisolone alone, and in one cyclosporin. Fetal loss at ⩾20 weeks' gestation occurred in two instances. Flares in disease activity occurred during four pregnancies and within three months of delivery in a further four. Among the 31 children born (median follow up 10 years) only two abnormalities have been identified: Perthes' disease in one and severe mental and physical handicap in a second who was born prematurely following decompensation of the mother's liver disease. Neither mother was receiving azathioprine.
CONCLUSIONS—Successful completion of pregnancy is a realistic expectation for patients with well controlled AIH. Treatment options vary, but azathioprine appears to be generally safe and without adverse outcomes for mother or baby. Vigilance is required, however, and patients need to be monitored carefully during pregnancy and for several months post partum.


Keywords: pregnancy; liver disease; autoimmune disease; azathioprine; corticosteroids

Full Text

The Full Text of this article is available as a PDF (132.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alstead E. M., Ritchie J. K., Lennard-Jones J. E., Farthing M. J., Clark M. L. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990 Aug;99(2):443–446. doi: 10.1016/0016-5085(90)91027-4. [DOI] [PubMed] [Google Scholar]
  2. Casson I. F., Clarke C. A., Howard C. V., McKendrick O., Pennycook S., Pharoah P. O., Platt M. J., Stanisstreet M., van Velszen D., Walkinshaw S. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ. 1997 Aug 2;315(7103):275–278. doi: 10.1136/bmj.315.7103.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colle I., Hautekeete M. Remission of autoimmune hepatitis during pregnancy: a report of two cases. Liver. 1999 Feb;19(1):55–57. doi: 10.1111/j.1478-3231.1999.tb00010.x. [DOI] [PubMed] [Google Scholar]
  4. Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
  5. Cundy T. F., Butler J., Pope R. M., Saggar-Malik A. K., Wheeler M. J., Williams R. Amenorrhoea in women with non-alcoholic chronic liver disease. Gut. 1991 Feb;32(2):202–206. doi: 10.1136/gut.32.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Davison J. M., Dellagrammatikas H., Parkin J. M. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol. 1985 Mar;92(3):233–239. doi: 10.1111/j.1471-0528.1985.tb01088.x. [DOI] [PubMed] [Google Scholar]
  7. DeWitte D. B., Buick M. K., Cyran S. E., Maisels M. J. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr. 1984 Oct;105(4):625–628. doi: 10.1016/s0022-3476(84)80435-7. [DOI] [PubMed] [Google Scholar]
  8. Erkman J., Blythe J. G. Azathioprine therapy complicated by pregnancy. Obstet Gynecol. 1972 Nov;40(5):708–710. [PubMed] [Google Scholar]
  9. Hegarty J. E., Nouri Aria K. T., Portmann B., Eddleston A. L., Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983 Sep-Oct;3(5):685–689. doi: 10.1002/hep.1840030510. [DOI] [PubMed] [Google Scholar]
  10. Hou S. Pregnancy in organ transplant recipients. Med Clin North Am. 1989 May;73(3):667–683. doi: 10.1016/s0025-7125(16)30665-4. [DOI] [PubMed] [Google Scholar]
  11. Johnson P. J., McFarlane I. G. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993 Oct;18(4):998–1005. doi: 10.1002/hep.1840180435. [DOI] [PubMed] [Google Scholar]
  12. Johnson P. J., McFarlane I. G., Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med. 1995 Oct 12;333(15):958–963. doi: 10.1056/NEJM199510123331502. [DOI] [PubMed] [Google Scholar]
  13. Meehan R. T., Dorsey J. K. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol. 1987 Apr;14(2):252–258. [PubMed] [Google Scholar]
  14. Meyer zum Büschenfelde K. H., Lohse A. W., Manns M., Poralla T. Autoimmunity and liver disease. Hepatology. 1990 Aug;12(2):354–363. doi: 10.1002/hep.1840120225. [DOI] [PubMed] [Google Scholar]
  15. Mistilis S. P., Skyring A. P., Blackburn C. R. Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival. Australas Ann Med. 1968 Aug;17(3):214–223. doi: 10.1111/imj.1968.17.3.214. [DOI] [PubMed] [Google Scholar]
  16. Murray-Lyon I. M., Stern R. B., Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973 Apr 7;1(7806):735–737. doi: 10.1016/s0140-6736(73)92125-9. [DOI] [PubMed] [Google Scholar]
  17. Powell E. E., Molloy D. Successful in vitro fertilization and pregnancy in a patient with autoimmune chronic active hepatitis and cirrhosis. J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):233–235. doi: 10.1111/j.1440-1746.1995.tb01084.x. [DOI] [PubMed] [Google Scholar]
  18. Present D. H., Meltzer S. J., Krumholz M. P., Wolke A., Korelitz B. I. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med. 1989 Oct 15;111(8):641–649. doi: 10.7326/0003-4819-111-8-641. [DOI] [PubMed] [Google Scholar]
  19. Rosenkrantz J. G., Githens J. H., Cox S. M., Kellum D. L. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol. 1967 Feb 1;97(3):387–394. doi: 10.1016/0002-9378(67)90503-0. [DOI] [PubMed] [Google Scholar]
  20. Saarikoski S., Seppälä M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol. 1973 Apr 15;115(8):1100–1106. doi: 10.1016/0002-9378(73)90559-0. [DOI] [PubMed] [Google Scholar]
  21. Soloway R. D., Summerskill W. H., Baggenstoss A. H., Geall M. G., Gitnićk G. L., Elveback I. R., Schoenfield L. J. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972 Nov;63(5):820–833. [PubMed] [Google Scholar]
  22. Sorokin J. J., Levine S. M. Pregnancy and inflammatory bowel disease: a review of the literature. Obstet Gynecol. 1983 Aug;62(2):247–252. [PubMed] [Google Scholar]
  23. Stellon A. J., Keating J. J., Johnson P. J., McFarlane I. G., Williams R. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology. 1988 Jul-Aug;8(4):781–784. doi: 10.1002/hep.1840080414. [DOI] [PubMed] [Google Scholar]
  24. Steven M. M., Buckley J. D., Mackay I. R. Pregnancy in chronic active hepatitis. Q J Med. 1979 Oct;48(192):519–531. [PubMed] [Google Scholar]
  25. THIERSCH J. B. Effect of 6-(1'-methyl-4'-nitro-5'-imidazolyl)-mercaptopurine and 2-amino-6-(1'-methyl-4'-nitro-5'-imidazolyl)-mercaptopurine on the rat litter in utero. J Reprod Fertil. 1962 Dec;4:297–302. doi: 10.1530/jrf.0.0040297. [DOI] [PubMed] [Google Scholar]
  26. Tuchmann-Duplessis H., Mercier-Parot L. Production chez le lapin de malformations des membres par administration d'azathioprine et de 6-mercaptopurine. C R Seances Soc Biol Fil. 1966;160(3):501–506. [PubMed] [Google Scholar]
  27. Vender R. J., Spiro H. M. Inflammatory bowel disease and pregnancy. J Clin Gastroenterol. 1982 Jun;4(3):231–249. doi: 10.1097/00004836-198206000-00008. [DOI] [PubMed] [Google Scholar]
  28. Whelton M. J., Sherlock S. Pregnancy in patients with hepatic cirrhosis. Management and outcome. Lancet. 1968 Nov 9;2(7576):995–999. doi: 10.1016/s0140-6736(68)91294-4. [DOI] [PubMed] [Google Scholar]
  29. Whitacre C. C., Reingold S. C., O'Looney P. A. A gender gap in autoimmunity. Science. 1999 Feb 26;283(5406):1277–1278. doi: 10.1126/science.283.5406.1277. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES